Access to Respiratory Syncytial Virus Preventive Tools for Neonates and Infants in Europe

• 2024

  Log in to bookmark this resource.

  Log in
• Caitlin Pley; Beate Kampmann
PMID: 38387473DOI: https://dx.doi.org/10.1016/S1473-3099%2824%2900084-7

---

Access Resources

• Journal ArticleEN
• Ask aRCie About This Resource

About

This comment discusses the limited access to respiratory syncytial virus (RSV) preventive tools for newborns and infants in Europe. RSV causes millions of pneumonia cases and over 100,000 deaths in children under 5 annually. Palivizumab, a monoclonal antibody, has been the sole preventive option for two decades, but its cost and short half-life (requiring five injections per season) limit its use to high-risk children. The article highlights the need for improved accessibility to RSV preventive measures to reduce the disease burden in this vulnerable population.

---

Tags

Focus Area: Infectious Disease

Audience: Physicians

Emergency Management Stage: Preparedness (Prevention / Protection)

Bundles: Nirsevimab Library

Keywords: Europe; Infant; Infant, Newborn; Respiratory Syncytial Virus Infections; Respiratory Syncytial Virus, Human

Institutions: Charité – Universitätsmedizin Berlin; London School of Hygiene & Tropical Medicine

---

More like this

The Respiratory Syncytial Virus Vaccine and Monoclonal Antibody Landscape: The Road to Global Access 2024 · University Medical Center Utrecht, Yenepoya University, University of Edinburgh, National Institutes of Health (NIH), London School of Hygiene and Tropical Medicine, London School of Hygiene & Tropical Medicine Development of a Pediatric Ebola Predictive Score, Sierra Leone 2018 · University College London, Save the Children, London School of Hygiene & Tropical Medicine Inequalities in Health Impact of Alternative Reimbursement Pathways for Nirsevimab in the United States 2022 · Sanofi, London School of Hygiene and Tropical Medicine, Brandeis University, London School of Hygiene & Tropical Medicine

---

The information provided on this website is for educational purposes only. It does not substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.

---